RAPID Excellence in Research: The development of ultrasensitive, multiplexed DNA/RNA detection platform using printed nanocomposite biosensors

  • Funded by National Science Foundation (NSF)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $199,993
  • Funder

    National Science Foundation (NSF)
  • Principal Investigator

    Honghe Wang
  • Research Location

    United States of America
  • Lead Research Institution

    Tuskegee University
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The COVID-19 pandemic presents a serious public health crisis to the United States and to the world at large. One critical need is for improved and simplified methods to detect the SARS-COV-2 virus. Many of the available tests lack specificity, take several hours to complete, and require centralized high-complexity laboratory equipment. Researchers supported by this award will develop and test a novel system for electrochemical detection of viral RNA sequences without the need for complex laboratory procedures. The work will be led by investigators at Tuskegee University, working in collaboration with Auburn University researchers. In addition to the potential societal benefit accrued from improved SARS-COV-2 testing, the undergraduate and graduate student training conducted as part of the project will help to advance and broaden the participation of students from HBCUs.

Electrochemical nanocomposite biosensors are powerful tools for the detection of biomarkers and environmental hazards. DNA or RNA fragments found in clinical samples typically fall below the detection limits of most methods of unamplified DNA/RNA detection. The research supported by this award will test the utility of simple nanocomposite sensor detecting DNA/RNA directly from unamplified samples. This technology offers an unprecedented simultaneous and multiplexed detection of different pathogen sequences in a high-throughput format with electrical readout. The simplified approach has the potential to dramatically reduce sample turnaround time due to their label free character and high sensitivity with a disposable ?sensor strip.? Results from these studies will be disseminated through publication in peer-reviewed journals, presentations at scientific meetings, and potentially through commercialization of the resulting technology. This RAPID award to Tuskegee University is made by the Division of Biological Infrastructure and is also supported by the NSF HBCU Excellence in Research Program.

This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.